TEVA PHARMACEUTICAL SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Dead...
October 06 2017 - 9:50PM
Business Wire
ClaimsFiler, a FREE shareholder information service, reminds
investors that they have until October 23, 2017 to file lead
plaintiff applications in a securities class action lawsuit against
Teva Pharmaceutical Industries Limited (NYSE: TEVA), if they
purchased the Company’s American Depository Shares (“ADSs”) and/or
shares on the Tel Aviv Stock Exchange between November 15, 2016 and
August 2, 2017, inclusive (the “Class Period”). This action is
pending in the United States District Court for the Eastern
District of Pennsylvania.
Get Help
Teva Pharmaceutical investors should visit us at
https://www.claimsfiler.com/cases/view-teva-pharmaceutical-industries-ltd-american-depository-shares-securities-litigation
or call to speak to our claim center toll-free at (844)
367-9658.
About the Lawsuit
Teva Pharmaceutical and certain of its executives are charged
with failing to disclose material information during the Class
Period, violating federal securities laws.
On August 3, 2017, Teva disclosed the recording of a goodwill
impairment charge of $6.1 billion for Q2 2017 related to the
acquisition of Actavis Generics as a result of poor performance in
its U.S. generics sector, as well as lower overall expected poor
performance due to increased competition and delays in product
launches.
On this news, the price of Teva Pharmaceutical’s shares
plummeted.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information
source to help retail investors recover their share of billions of
dollars from securities class action settlements. ClaimsFiler's
team of experts monitor the securities class action landscape and
cull information from a variety of sources to ensure comprehensive
coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171006005021/en/
ClaimsFilerJerry Gallo,
844-367-9658https://www.claimsfiler.com
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Apr 2024 to May 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From May 2023 to May 2024